Tracazolate hydrochloride exhibits anxiolytic and anticonvulsant activities; it acts as a positive allosteric modulator of GABAA receptors, enhancing the function of various GABAA receptor subtypes (e.g., α1β1γ2s, α1β3γ2, α1β2δ), and also interacts with adenosine receptors and phosphodiesterases.